Pharma project marks ground-breaking at Khazaen: Oman

Getty Images

Total investment in the project, set on a 37,000 sq metre plot, is about RO 60 million

Staff Writer, Oman Daily Observer

July 12, 2023

PHOTO

MUSCAT: Opal Bio Pharma, a health sciences company, celebrated on Wednesday the groundbreaking ceremony of the second phase of its pharmaceutical project at Khazaen Economic City.

Total investment in the project, set on a 37,000 sq metre plot, is about RO 60 million.

The factory, scheduled to commence production in the fourth quarter of 2024, will produce a range of vital drugs that will help reduce Oman’s reliance on imports and bolster national pharma security.

It will also support Oman’s positioning as a regional center for vaccine and pharma production.

Projected to be complete in two years, the plant is expected to be a new pharmaceutical landmark in Oman and the Middle East, with its products targeted for export worldwide.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.